BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33569406)

  • 1. RNA-binding protein QKI suppresses breast cancer via RASA1/MAPK signaling pathway.
    Cao Y; Chu C; Li X; Gu S; Zou Q; Jin Y
    Ann Transl Med; 2021 Jan; 9(2):104. PubMed ID: 33569406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-binding protein QKI-5 inhibits the proliferation of clear cell renal cell carcinoma via post-transcriptional stabilization of RASA1 mRNA.
    Zhang RL; Yang JP; Peng LX; Zheng LS; Xie P; Wang MY; Cao Y; Zhang ZL; Zhou FJ; Qian CN; Bao YX
    Cell Cycle; 2016 Nov; 15(22):3094-3104. PubMed ID: 27767378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GAS5 regulated by FTO-mediated m6A modification suppresses cell proliferation via the IGF2BP2/QKI axis in breast cancer.
    Yan Y; Ma J; Chen Q; Zhang T; Fan R; Du J
    Discov Oncol; 2024 May; 15(1):182. PubMed ID: 38782769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long noncoding RNA MEG3 regulates Ras-MAPK pathway through RASA1 in trophoblast and is associated with unexplained recurrent spontaneous abortion.
    Zhang J; Liu X; Gao Y
    Mol Med; 2021 Jul; 27(1):70. PubMed ID: 34238211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of epithelial-mesenchymal transition related genes: SLUG and QKI in breast cancer patients.
    Gu S; Chu C; Chen W; Ren H; Cao Y; Li X; He J; Wang Y; Jin Y; Liu X; Zou Q
    Int J Clin Exp Pathol; 2019; 12(6):2009-2021. PubMed ID: 31934023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QKI-5 suppresses cyclin D1 expression and proliferation of oral squamous cell carcinoma cells via MAPK signalling pathway.
    Fu X; Feng Y
    Int J Oral Maxillofac Surg; 2015 May; 44(5):562-7. PubMed ID: 25457822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding protein QKI promotes the progression of HCC by interacting with long non-coding RNA EGOT.
    Lu Y; Yang Z; Zhang J; Ma X; Bi X; Xu L; Feng K; Wu Z; Ma X; Zhuang L
    Int Immunopharmacol; 2024 May; 136():112297. PubMed ID: 38810307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QKI-6 Suppresses Cell Proliferation, Migration, and EMT in Non-Small Cell Lung Cancer.
    Zhang H; Li J; Tian F; Su X; Wang X; Tang D; Zhang L; Zhang T; Ni Y
    Front Oncol; 2022; 12():897553. PubMed ID: 35600368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155 promotes the proliferation and invasion abilities of colon cancer cells by targeting quaking.
    He B; Gao SQ; Huang LD; Huang YH; Zhang QY; Zhou MT; Shi HQ; Song QT; Shan YF
    Mol Med Rep; 2015 Mar; 11(3):2355-9. PubMed ID: 25420938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
    Liu X; Xu Y; Deng Y; Li H
    Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA‑4530 suppresses cell proliferation and induces apoptosis by targeting RASA1 in human umbilical vein endothelial cells.
    Jing L; Li H; Zhang T; Lu J; Zhong L
    Mol Med Rep; 2019 May; 19(5):3393-3402. PubMed ID: 30864691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circRNA_0000518 facilitates breast cancer development via regulation of the miR-326/FGFR1 axis.
    Jiang J; Lin H; Shi S; Hong Y; Bai X; Cao X
    Thorac Cancer; 2020 Nov; 11(11):3181-3192. PubMed ID: 33000910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00483 is regulated by IGF2BP1 and participates in the progression of breast cancer.
    Qiao YS; Zhou JH; Jin BH; Wu YQ; Zhao B
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1379-1386. PubMed ID: 33629308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs 206 and 21 cooperate to promote RAS-extracellular signal-regulated kinase signaling by suppressing the translation of RASA1 and SPRED1.
    Sharma SB; Lin CC; Farrugia MK; McLaughlin SL; Ellis EJ; Brundage KM; Salkeni MA; Ruppert JM
    Mol Cell Biol; 2014 Nov; 34(22):4143-64. PubMed ID: 25202123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIF18B promotes breast cancer cell proliferation, migration and invasion by targeting TRIP13 and activating the Wnt/β-catenin signaling pathway.
    Liu L; Zhang Z; Xia X; Lei J
    Oncol Lett; 2022 Apr; 23(4):112. PubMed ID: 35251343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
    Ding L; Xie Z
    Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis.
    Chen FY; Zhou ZY; Zhang KJ; Pang J; Wang SM
    Cancer Cell Int; 2020; 20():508. PubMed ID: 33088216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of nucleophosmin 1 suppresses proliferation of triple-negative breast cancer cells through activating CDH1/Skp2/p27kip1 pathway.
    Zeng D; Xiao Y; Zhu J; Peng C; Liang W; Lin H
    Cancer Manag Res; 2019; 11():143-156. PubMed ID: 30613163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1.
    Hu C; Huang F; Deng G; Nie W; Huang W; Zeng X
    Exp Ther Med; 2013 Nov; 6(5):1265-1270. PubMed ID: 24223656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
    Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.